...
phio-img

Phio Pharmaceuticals Corp, Common Stock

PHIO

NAQ

$2.76

+$0.06

(2.22%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$2.02M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
13.30K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.47
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$2.17 L
$10.35 H
$2.76

About Phio Pharmaceuticals Corp, Common Stock

Phio Pharmaceuticals Corp. engages in the development of immuno-oncology therapeutics in the United States. The company is developing PH-762, an INTASYL compound in Phase 1b dose-escalating clinical trials to reduce the expression of cell death protein 1 (PD-1), a protein that inhibits T cells' ability to kill cancer cells; and PH-762 treated double positive tumor infiltrating lymphocytes, which is in Phase 1 clinical trials to treat advanced melanoma and other advanced solid tumors. It is also developing PH-894, an INTASYL compound in IND enabling studies to silence BRD4, a protein that controls gene expression in both T cells and tumor cells, effecting the immune system and the tumor. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was incorporated in 2011 and is based in Marlborough, Massachusetts. more

Industry: BiotechnologySector: Health Care

Returns

Time FramePHIOSectorS&P500
1-Week Return-3.91%-3.39%0.2%
1-Month Return18.94%-1.92%2.72%
3-Month Return-26.94%-10.54%7.31%
6-Month Return-59.02%-4.47%10.44%
1-Year Return-60.91%4.06%27.53%
3-Year Return-97.86%0.94%30.88%
5-Year Return-99.65%36.67%89.21%
10-Year Return-100%102.87%199.95%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue21.00K4.36K---[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":20.77,"profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Cost of Revenue4.30M183.00K192.00K193.00K6.33M[{"date":"2019-12-31","value":67.91,"profit":true},{"date":"2020-12-31","value":2.89,"profit":true},{"date":"2021-12-31","value":3.03,"profit":true},{"date":"2022-12-31","value":3.05,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Gross Profit21.00K(183.00K)(192.00K)(193.00K)(6.33M)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-871.43,"profit":false},{"date":"2021-12-31","value":-914.29,"profit":false},{"date":"2022-12-31","value":-919.05,"profit":false},{"date":"2023-12-31","value":-30152.38,"profit":false}]
Gross Margin100.00%(4195.32%)(Infinity%)(Infinity%)(Infinity%)[{"date":"2019-12-31","value":100,"profit":true},{"date":"2020-12-31","value":-4195.32,"profit":false},{"date":"2021-12-31","value":null,"profit":false},{"date":"2022-12-31","value":null,"profit":false},{"date":"2023-12-31","value":null,"profit":false}]
Operating Expenses9.01M8.79M13.51M11.46M4.49M[{"date":"2019-12-31","value":66.67,"profit":true},{"date":"2020-12-31","value":65.08,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":84.83,"profit":true},{"date":"2023-12-31","value":33.25,"profit":true}]
Operating Income(8.99M)(8.79M)(13.51M)(11.46M)(10.82M)[{"date":"2019-12-31","value":-898700000,"profit":false},{"date":"2020-12-31","value":-879300000,"profit":false},{"date":"2021-12-31","value":-1351100000,"profit":false},{"date":"2022-12-31","value":-1146200000,"profit":false},{"date":"2023-12-31","value":-1082400000,"profit":false}]
Total Non-Operating Income/Expense-(2.00K)215.00K--[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-0.93,"profit":false},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Pre-Tax Income(8.91M)(8.79M)(13.29M)(11.48M)(10.83M)[{"date":"2019-12-31","value":-890800000,"profit":false},{"date":"2020-12-31","value":-879400000,"profit":false},{"date":"2021-12-31","value":-1328700000,"profit":false},{"date":"2022-12-31","value":-1148000000,"profit":false},{"date":"2023-12-31","value":-1082600000,"profit":false}]
Income Taxes(67.00K)(134.30K)(75.00K)(175.00K)204.00K[{"date":"2019-12-31","value":-32.84,"profit":false},{"date":"2020-12-31","value":-65.83,"profit":false},{"date":"2021-12-31","value":-36.76,"profit":false},{"date":"2022-12-31","value":-85.78,"profit":false},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes-(8.66M)(13.21M)--[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":-865970300,"profit":false},{"date":"2021-12-31","value":-1321200000,"profit":false},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income From Continuous Operations(8.91M)(8.79M)(13.29M)(11.48M)(11.66M)[{"date":"2019-12-31","value":-890800000,"profit":false},{"date":"2020-12-31","value":-879400000,"profit":false},{"date":"2021-12-31","value":-1328700000,"profit":false},{"date":"2022-12-31","value":-1148000000,"profit":false},{"date":"2023-12-31","value":-1166200000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(8.84M)(8.79M)(13.21M)(11.30M)(10.83M)[{"date":"2019-12-31","value":-884100000,"profit":false},{"date":"2020-12-31","value":-879400000,"profit":false},{"date":"2021-12-31","value":-1321200000,"profit":false},{"date":"2022-12-31","value":-1130500000,"profit":false},{"date":"2023-12-31","value":-1082600000,"profit":false}]
EPS (Diluted)(115.79)(15.13)(9.32)(10.08)(6.62)[{"date":"2019-12-31","value":-11579,"profit":false},{"date":"2020-12-31","value":-1513,"profit":false},{"date":"2021-12-31","value":-932,"profit":false},{"date":"2022-12-31","value":-1008,"profit":false},{"date":"2023-12-31","value":-661.82,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

PHIO
Cash Ratio 5.87
Current Ratio 6.38

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

PHIO
ROA (LTM) -61.07%
ROE (LTM) -126.86%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

PHIO
Debt Ratio Lower is generally better. Negative is bad. 0.16
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.84

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

PHIO
Trailing PE NM
Forward PE 0.31
P/S (TTM) 48.01
P/B 0.61
Price/FCF NM
EV/R 172.20
EV/Ebitda 0.61

FAQs

What is Phio Pharmaceuticals Corp share price today?

Phio Pharmaceuticals Corp (PHIO) share price today is $2.76

Can Indians buy Phio Pharmaceuticals Corp shares?

Yes, Indians can buy shares of Phio Pharmaceuticals Corp (PHIO) on Vested. To buy Phio Pharmaceuticals Corp from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in PHIO stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Phio Pharmaceuticals Corp be purchased?

Yes, you can purchase fractional shares of Phio Pharmaceuticals Corp (PHIO) via the Vested app. You can start investing in Phio Pharmaceuticals Corp (PHIO) with a minimum investment of $1.

How to invest in Phio Pharmaceuticals Corp shares from India?

You can invest in shares of Phio Pharmaceuticals Corp (PHIO) via Vested in three simple steps:

  • Click on Sign Up or Invest in PHIO stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Phio Pharmaceuticals Corp shares
What is Phio Pharmaceuticals Corp 52-week high and low stock price?

The 52-week high price of Phio Pharmaceuticals Corp (PHIO) is $10.35. The 52-week low price of Phio Pharmaceuticals Corp (PHIO) is $2.17.

What is Phio Pharmaceuticals Corp price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Phio Pharmaceuticals Corp (PHIO) is

What is Phio Pharmaceuticals Corp price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Phio Pharmaceuticals Corp (PHIO) is 0.61

What is Phio Pharmaceuticals Corp dividend yield?

The dividend yield of Phio Pharmaceuticals Corp (PHIO) is 0.00%

What is the Market Cap of Phio Pharmaceuticals Corp?

The market capitalization of Phio Pharmaceuticals Corp (PHIO) is $2.02M

What is Phio Pharmaceuticals Corp’s stock symbol?

The stock symbol (or ticker) of Phio Pharmaceuticals Corp is PHIO

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top